Deciphera Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance
Deciphera Pharmaceuticals, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2024-02-07
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-07 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-07 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-07 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-08 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |